Alembic intros generic Corlanor
Ivabradine tablets are indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction.
Alembic is launching ivabradine tablets, 5 mg and 7.5 mg, which are the generic of Amgen’s Corlanor tablets.
Ivabradine tablets are hyperpolarization-activated cyclic nucleotide-gated channel blockers indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction.
[Read more: Alembic gets FDA tentative OK for generic Bosulif]
Alembic 's ivabradine tablets in strengths of 5 mg and 7.5 mg, are both available in 60-count bottles.
[Read more: Alembic unveils 2 generics]